The QLQ-C30 and EQ-5D-5L data were collected from 237 breast cancer patients in the first phase. The data was collected using a 5L scale. The study assessed the ceiling and floor effects, correlation, convergent validity, and construct validity. To test the test-retest reliability, 47 patients were recruited after 7 days. B&A plots and ICC were used for this analysis. After 3 months, data from 177 patients was collected to calculate the response of QLU-C10D.


原文地址: https://www.cveoy.top/t/topic/nmct 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录